sr_773529

Leading injection moulder, Boddingtons, will bring its medical injection moulding expertise to the Medical Technology Ireland exhibition for the first time.

Boddingtons will offer turnkey medical moulding and manufacturing from concept through to shipping. Market demand sees the new Boddingtons Class 7 clean room – capable of making Class 1 and 2 medical devices  – already being extended. And Boddingtons is one of the first global injection moulders invited to now register for the new international MDSAP Medical QA standard.

Medical Technology Ireland will take place at Galway Racecourse on September 25-26, 2019. Over 200 suppliers to the industry will exhibit alongside an innovative conference programme.

Andy Tibbs, Boddingtons CEO, says that ‘Boddingtons is delighted to be taking part in this prestige event for the Irish medical industry. We shall put the full range of our manufacturing and medical services in the service of the Irish medical sector and thereby hope to do good business.’

medtech (002)

Chris Philpott, Business Development Manager and Andy Tibbs, CEO will be available to welcome visitors to the stand – Ground floor 82

Boddingtons enjoyed a successful experience at the UK’s Med-Tech exhibition, NEC Birmingham in May 2019. And November 18-21 sees the business exhibiting at the Medica Compamed exhibition, Düsseldorf, for the 3rd year in succession.

Since the launch of its £4.6m manufacturing facility in early 2017, Boddingtons has steadily expanded the scope and volume of its med-tech manufacturing services. The company is certified to ISO13485 and ISO9001 Quality Management Systems Requirements and is also compliant with FDA 21 CFR Part 820.

Andy Tibbs adds that ‘our aim at Boddingtons is to be nothing less than a world-class supplier of injection moulding competences to the global medical and healthcare sectors – from first concepts to final assembly and shipping and all manufacturing and injection moulding points in between. We invite all in the sector to partner with us for future growth.’

Leave a Reply

Your email address will not be published. Required fields are marked *